QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (168) Citing Articles via Google Scholar Google Scholar Articles by Vekrellis, K. Articles by Selkoe, D. J. Search for Related Content PubMed PubMed Citation Articles by Vekrellis, K. Articles by Selkoe, D. J.

 Previous Article  |  Next Article 

The Journal of Neuroscience, March 1, 2000, 20(5):1657-1665

Neurons Regulate Extracellular Levels of Amyloid -Protein via Proteolysis by Insulin-Degrading Enzyme

Konstantinos Vekrellis¹, Zhen Ye¹, Wei Qiao Qiu¹, Dominic Walsh¹, Dean Hartley¹, Valérie Chesneau², Marsha Rich Rosner², and Dennis J. Selkoe¹

¹ Center for Neurologic Diseases, Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts 02115, and ² Ben May Institute for Cancer Research, University of Chicago, Chicago, Illinois 60637

Progressive cerebral accumulation of amyloid -protein (A) is an early and invariant feature of Alzheimer's disease. Little is known about how A, after being secreted, is degraded and cleared from the extracellular space of the brain. Defective A degradation could be a risk factor for the development of Alzheimer's disease in some subjects. We reported previously that microglial cells release substantial amounts of an A-degrading protease that, after purification, is indistinguishable from insulin-degrading enzyme (IDE). Here we searched for and characterized a role for IDE in A degradation by neurons, the principal cell type that produces A. Whole cultures of differentiated pheochromocytoma (PC12) cells and primary rat cortical neurons actively degraded endogenously secreted A via IDE. However, unlike that in microglia, IDE in differentiated neurons was not released but localized to the cell surface, as demonstrated by biotinylation. Undifferentiated PC12 cells released IDE into their medium, whereas after differentiation, IDE was cell associated but still degraded A in the medium. Overexpression of IDE in mammalian cells markedly reduced the steady-state levels of extracellular A₄₀ and A₄₂, and the catalytic site mutation (E111Q) abolished this effect. We observed a novel membrane-associated form of IDE that is ~5 kDa larger than the known cytosolic form in a variety of cells, including differentiated PC12 cells. Our results support a principal role for membrane-associated and secreted IDE isoforms in the degradation and clearance of naturally secreted A by neurons and microglia.

Key words: neurons; Alzheimer's disease; amyloid -protein degradation; insulin-degrading enzyme; oligomerization; membrane proteins

---

Copyright © 2000 Society for Neuroscience  0270-6474/00/2051657-09$05.00/0

This article has been cited by other articles:

				M. Neant-Fery, R. D. Garcia-Ordonez, T. P. Logan, D. J. Selkoe, L. Li, L. Reinstatler, and M. A. Leissring Molecular basis for the thiol sensitivity of insulin-degrading enzyme PNAS, July 15, 2008; 105(28): 9582 - 9587. [Abstract] [Full Text] [PDF]

				D. M. Hartley, C. Zhao, A. C. Speier, G. A. Woodard, S. Li, Z. Li, and T. Walz Transglutaminase Induces Protofibril-like Amyloid {beta}-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation J. Biol. Chem., June 13, 2008; 283(24): 16790 - 16800. [Abstract] [Full Text] [PDF]

				C. T. Kodl and E. R. Seaquist Cognitive Dysfunction and Diabetes Mellitus Endocr. Rev., June 1, 2008; 29(4): 494 - 511. [Abstract] [Full Text] [PDF]

				W. Farris, S. G. Schutz, J. R. Cirrito, G. M. Shankar, X. Sun, A. George, M. A. Leissring, D. M. Walsh, W. Q. Qiu, D. M. Holtzman, et al. Loss of Neprilysin Function Promotes Amyloid Plaque Formation and Causes Cerebral Amyloid Angiopathy Am. J. Pathol., July 1, 2007; 171(1): 241 - 251. [Abstract] [Full Text] [PDF]

				M. Kim, L. B. Hersh, M. A. Leissring, M. Ingelsson, T. Matsui, W. Farris, A. Lu, B. T. Hyman, D. J. Selkoe, L. Bertram, et al. Decreased Catalytic Activity of the Insulin-degrading Enzyme in Chromosome 10-Linked Alzheimer Disease Families J. Biol. Chem., March 16, 2007; 282(11): 7825 - 7832. [Abstract] [Full Text] [PDF]

				C. K. Chai The Genetics of Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, February 1, 2007; 22(1): 37 - 41. [Abstract] [PDF]

				C. G. Evans, S. Wisen, and J. E. Gestwicki Heat Shock Proteins 70 and 90 Inhibit Early Stages of Amyloid beta-(1-42) Aggregation in Vitro J. Biol. Chem., November 3, 2006; 281(44): 33182 - 33191. [Abstract] [Full Text] [PDF]

				K.-J. Yin, J. R. Cirrito, P. Yan, X. Hu, Q. Xiao, X. Pan, R. Bateman, H. Song, F.-F. Hsu, J. Turk, et al. Matrix Metalloproteinases Expressed by Astrocytes Mediate Extracellular Amyloid-beta Peptide Catabolism J. Neurosci., October 25, 2006; 26(43): 10939 - 10948. [Abstract] [Full Text] [PDF]

				M. L. Hemming and D. J. Selkoe Amyloid {beta}-Protein Is Degraded by Cellular Angiotensin-converting Enzyme (ACE) and Elevated by an ACE Inhibitor J. Biol. Chem., November 11, 2005; 280(45): 37644 - 37650. [Abstract] [Full Text] [PDF]

				J. A. Luchsinger, C. Reitz, L. S. Honig, M. X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology, August 23, 2005; 65(4): 545 - 551. [Abstract] [Full Text] [PDF]

				E. S. Song, A. Daily, M. G. Fried, M. A. Juliano, L. Juliano, and L. B. Hersh Mutation of Active Site Residues of Insulin-degrading Enzyme Alters Allosteric Interactions J. Biol. Chem., May 6, 2005; 280(18): 17701 - 17706. [Abstract] [Full Text] [PDF]

				E. B. Lee, B. Zhang, K. Liu, E. A. Greenbaum, R. W. Doms, J. Q. Trojanowski, and V. M.-Y. Lee BACE overexpression alters the subcellular processing of APP and inhibits A{beta} deposition in vivo J. Cell Biol., January 17, 2005; 168(2): 291 - 302. [Abstract] [Full Text] [PDF]

				L. Morelli, R. E. Llovera, I. Mathov, L.-F. Lue, B. Frangione, J. Ghiso, and E. M. Castano Insulin-degrading Enzyme in Brain Microvessels: PROTEOLYSIS OF AMYLOID {beta} VASCULOTROPIC VARIANTS AND REDUCED ACTIVITY IN CEREBRAL AMYLOID ANGIOPATHY J. Biol. Chem., December 31, 2004; 279(53): 56004 - 56013. [Abstract] [Full Text] [PDF]

				L. Zhao, B. Teter, T. Morihara, G. P. Lim, S. S. Ambegaokar, O. J. Ubeda, S. A. Frautschy, and G. M. Cole Insulin-Degrading Enzyme as a Downstream Target of Insulin Receptor Signaling Cascade: Implications for Alzheimer's Disease Intervention J. Neurosci., December 8, 2004; 24(49): 11120 - 11126. [Abstract] [Full Text] [PDF]

				L. de Yebra, R. Adroer, N. de Gregorio-Rocasolano, R. Blesa, R. Trullas, and N. Mahy Reduced KIAA0471 mRNA expression in Alzheimer's patients: a new candidate gene product linked to the disease? Hum. Mol. Genet., November 1, 2004; 13(21): 2607 - 2612. [Abstract] [Full Text] [PDF]

				J. A. Luchsinger, M.-X. Tang, S. Shea, and R. Mayeux Hyperinsulinemia and risk of Alzheimer disease Neurology, October 12, 2004; 63(7): 1187 - 1192. [Abstract] [Full Text] [PDF]

				R. L. Hull, G. T. Westermark, P. Westermark, and S. E. Kahn Islet Amyloid: A Critical Entity in the Pathogenesis of Type 2 Diabetes J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3629 - 3643. [Abstract] [Full Text] [PDF]

				L. Bian, J. D. Yang, T. W. Guo, Y. Sun, S. W. Duan, W. Y. Chen, Y. X. Pan, G. Y. Feng, and L. He Insulin-degrading enzyme and Alzheimer disease: A genetic association study in the Han Chinese Neurology, July 27, 2004; 63(2): 241 - 245. [Abstract] [Full Text] [PDF]

				Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. A. Evans, and D. A. Bennett Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function Arch Neurol, May 1, 2004; 61(5): 661 - 666. [Abstract] [Full Text] [PDF]

				W. Farris, S. Mansourian, M. A. Leissring, E. A. Eckman, L. Bertram, C. B. Eckman, R. E. Tanzi, and D. J. Selkoe Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid {beta}-Protein Am. J. Pathol., April 1, 2004; 164(4): 1425 - 1434. [Abstract] [Full Text] [PDF]

				E.-S. Song, M. A. Juliano, L. Juliano, and L. B. Hersh Substrate Activation of Insulin-degrading Enzyme (Insulysin): A POTENTIAL TARGET FOR DRUG DEVELOPMENT J. Biol. Chem., December 12, 2003; 278(50): 49789 - 49794. [Abstract] [Full Text] [PDF]

				J. N. Henderson, J. Zhang, B. W. Evans, and K. Redding Disassembly and Degradation of Photosystem I in an in Vitro System Are Multievent, Metal-dependent Processes J. Biol. Chem., October 10, 2003; 278(41): 39978 - 39986. [Abstract] [Full Text] [PDF]

				M. A. Leissring, A. Lu, M. M. Condron, D. B. Teplow, R. L. Stein, W. Farris, and D. J. Selkoe Kinetics of Amyloid {beta}-Protein Degradation Determined by Novel Fluorescence- and Fluorescence Polarization-based Assays J. Biol. Chem., September 26, 2003; 278(39): 37314 - 37320. [Abstract] [Full Text] [PDF]

				R. G. Bennett, F. G. Hamel, and W. C. Duckworth An Insulin-Degrading Enzyme Inhibitor Decreases Amylin Degradation, Increases Amylin-Induced Cytotoxicity, and Increases Amyloid Formation in Insulinoma Cell Cultures Diabetes, September 1, 2003; 52(9): 2315 - 2320. [Abstract] [Full Text] [PDF]

				G. S. Watson, E. R. Peskind, S. Asthana, K. Purganan, C. Wait, D. Chapman, M. W. Schwartz, S. Plymate, and S. Craft Insulin increases CSF A{beta}42 levels in normal older adults Neurology, June 24, 2003; 60(12): 1899 - 1903. [Abstract] [Full Text] [PDF]

				B. C. Miller, E. A. Eckman, K. Sambamurti, N. Dobbs, K. M. Chow, C. B. Eckman, L. B. Hersh, and D. L. Thiele Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo PNAS, May 13, 2003; 100(10): 6221 - 6226. [Abstract] [Full Text] [PDF]

				G. V. Gassen and W. Annaert Amyloid, Presenilins, and Alzheimer's Disease Neuroscientist, April 1, 2003; 9(2): 117 - 126. [Abstract] [PDF]

				W. Farris, S. Mansourian, Y. Chang, L. Lindsley, E. A. Eckman, M. P. Frosch, C. B. Eckman, R. E. Tanzi, D. J. Selkoe, and S. Guenette Insulin-degrading enzyme regulates the levels of insulin, amyloid beta -protein, and the beta -amyloid precursor protein intracellular domain in vivo PNAS, April 1, 2003; 100(7): 4162 - 4167. [Abstract] [Full Text] [PDF]

				A. B. Goodman and A. B. Pardee Evidence for defective retinoid transport and function in late onset Alzheimer's disease PNAS, March 4, 2003; 100(5): 2901 - 2905. [Abstract] [Full Text] [PDF]

				E. A. Eckman, M. Watson, L. Marlow, K. Sambamurti, and C. B. Eckman Alzheimer's Disease beta -Amyloid Peptide Is Increased in Mice Deficient in Endothelin-converting Enzyme J. Biol. Chem., January 17, 2003; 278(4): 2081 - 2084. [Abstract] [Full Text] [PDF]

				D. G. Cook, J. B. Leverenz, P. J. McMillan, J. J. Kulstad, S. Ericksen, R. A. Roth, G. D. Schellenberg, L.-W. Jin, K. S. Kovacina, and S. Craft Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-{epsilon}4 Allele Am. J. Pathol., January 1, 2003; 162(1): 313 - 319. [Abstract] [Full Text] [PDF]

				C. N. Shrimpton, A. I. Smith, and R. A. Lew Soluble Metalloendopeptidases and Neuroendocrine Signaling Endocr. Rev., October 1, 2002; 23(5): 647 - 664. [Abstract] [Full Text] [PDF]

				M. H. Mohajeri, M. A. Wollmer, and R. M. Nitsch Abeta 42-induced Increase in Neprilysin Is Associated with Prevention of Amyloid Plaque Formation in Vivo J. Biol. Chem., September 13, 2002; 277(38): 35460 - 35465. [Abstract] [Full Text] [PDF]

				Y.-H. Suh and F. Checler Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525. [Abstract] [Full Text] [PDF]

				D. Edbauer, M. Willem, S. Lammich, H. Steiner, and C. Haass Insulin-degrading Enzyme Rapidly Removes the beta -Amyloid Precursor Protein Intracellular Domain (AICD) J. Biol. Chem., April 12, 2002; 277(16): 13389 - 13393. [Abstract] [Full Text] [PDF]

				S Lovestone and D M McLoughlin Protein aggregates and dementia: is there a common toxicity? J. Neurol. Neurosurg. Psychiatry, February 1, 2002; 72(2): 152 - 161. [Abstract] [Full Text] [PDF]

				K. Uryu, H. Laurer, T. McIntosh, D. Pratico, D. Martinez, S. Leight, V. M.-Y. Lee, and J. Q. Trojanowski Repetitive Mild Brain Trauma Accelerates Abeta Deposition, Lipid Peroxidation, and Cognitive Impairment in a Transgenic Mouse Model of Alzheimer Amyloidosis J. Neurosci., January 15, 2002; 22(2): 446 - 454. [Abstract] [Full Text] [PDF]

				N. Iwata, S. Tsubuki, Y. Takaki, K. Shirotani, B. Lu, N. P. Gerard, C. Gerard, E. Hama, H.-J. Lee, and T. C. Saido Metabolic Regulation of Brain Abeta by Neprilysin Science, May 25, 2001; 292(5521): 1550 - 1552. [Abstract] [Full Text] [PDF]

				L. Gasparini, G. K. Gouras, R. Wang, R. S. Gross, M. F. Beal, P. Greengard, and H. Xu Stimulation of {beta}-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal {beta}-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling J. Neurosci., April 15, 2001; 21(8): 2561 - 2570. [Abstract] [Full Text] [PDF]

				L. Bertram, D. Blacker, K. Mullin, D. Keeney, J. Jones, S. Basu, S. Yhu, M. G. McInnis, R. C. P. Go, K. Vekrellis, et al. Evidence for Genetic Linkage of Alzheimer's Disease to Chromosome 10q Science, December 22, 2000; 290(5500): 2302 - 2303. [Abstract] [Full Text]

				A. Mukherjee, E.-s. Song, M. Kihiko-Ehmann, J. P. Goodman Jr, J. St. Pyrek, S. Estus, and L. B. Hersh Insulysin Hydrolyzes Amyloid beta Peptides to Products That Are Neither Neurotoxic Nor Deposit on Amyloid Plaques J. Neurosci., December 1, 2000; 20(23): 8745 - 8749. [Abstract] [Full Text] [PDF]

				I. Dewachter, J. Van Dorpe, L. Smeijers, M. Gilis, C. Kuiperi, I. Laenen, N. Caluwaerts, D. Moechars, F. Checler, H. Vanderstichele, et al. Aging Increased Amyloid Peptide and Caused Amyloid Plaques in Brain of Old APP/V717I Transgenic Mice by a Different Mechanism than Mutant Presenilin1 J. Neurosci., September 1, 2000; 20(17): 6452 - 6458. [Abstract] [Full Text] [PDF]

				R. G. Bennett, W. C. Duckworth, and F. G. Hamel Degradation of Amylin by Insulin-degrading Enzyme J. Biol. Chem., November 17, 2000; 275(47): 36621 - 36625. [Abstract] [Full Text] [PDF]

				E. A. Eckman, D. K. Reed, and C. B. Eckman Degradation of the Alzheimer's Amyloid beta Peptide by Endothelin-converting Enzyme J. Biol. Chem., June 29, 2001; 276(27): 24540 - 24548. [Abstract] [Full Text] [PDF]

				K. Shirotani, S. Tsubuki, N. Iwata, Y. Takaki, W. Harigaya, K. Maruyama, S. Kiryu-Seo, H. Kiyama, H. Iwata, T. Tomita, et al. Neprilysin Degrades Both Amyloid beta Peptides 1-40 and 1-42 Most Rapidly and Efficiently among Thiorphan- and Phosphoramidon-sensitive Endopeptidases J. Biol. Chem., June 8, 2001; 276(24): 21895 - 21901. [Abstract] [Full Text] [PDF]

				E.-S. Song, A. Mukherjee, M. A. Juliano, J. St. Pyrek, J. P. Goodman Jr., L. Juliano, and L. B. Hersh Analysis of the Subsite Specificity of Rat Insulysin Using Fluorogenic Peptide Substrates J. Biol. Chem., January 5, 2001; 276(2): 1152 - 1155. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help